Gilead Sciences Inc
NASDAQ: GILD
$84.59
Closing Price on October 4, 2024
GILD Articles
The bear market rally that started in June is over and it is clearly a time to move to safer dividend stocks. These eight outstanding health care stocks make sense for worried investors now as they...
Published:
Wednesday’s top analyst upgrades and downgrades included Apple, Carvana, Elanco Animal Health, Gilead Sciences, Home Depot, Park Hotels & Resorts, Shoals Technologies, SNDL, SITE Centers and UDR.
Published:
Thursday’s top analyst upgrades and downgrades included Advanced Micro Devices, Baxter International, Caesars Entertainment, Electronic Arts, Exact Sciences, Gilead Sciences, Intel, JetBlue...
Published:
Wednesday's top analyst upgrades and downgrades included Apollo Global Management, Asana, Block, Caesars Entertainment, Dollar General, Gilead Sciences, Goldman Sachs, Invitation Homes, Medtronic,...
Published:
One big advantage to buying beaten-down stocks with substantial dividends is that one is paid to wait for the recovery. These six well-known stocks have been hammered but look like solid ideas for...
Published:
These seven top stocks may be somewhat off the radar, but the companies have a reasonably strong moat around their businesses, generous dividends and stocks with outstanding entry points now.
Published:
Friday's top analyst upgrades and downgrades included AppLovin, BioCryst Pharmaceuticals, Boeing, CF Industries, Coupa Software, Crocs, Dutch Bros, DigitalOcean, Gilead Sciences, IBM, International...
Published:
Last Updated:
The tech-heavy Nasdaq is firmly in bear market territory. Yet, its highest-yielding stocks have solid defensive qualities and are offering patient investors some of the best entry points in years and...
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, Apple, Caterpillar, Comcast, Comerica, Gilead Sciences, Intel, Lululemon Athletica and McDonald's.
Published:
Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Danaher, DoorDash, Freeport-McMoRan, Gap, Gilead Sciences, Huntington Bancshares, Independence Realty Trust, Intuitive...
Published:
History shows that placing bets on sector laggards has paid off handsomely for investors, according to a new research report. These eight diverse underperforming stocks also come with healthy and...
Published:
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall...
Published:
While income and growth investors may not look to the Nasdaq for total return, there are some gems in the index that make sense for investors now. The five highest-yielding Nasdaq stocks now offer...
Published:
These six Goldman Sachs stock picks offer a blend of high dividend yield and strong forecast dividend growth, making them ideal for income and growth investors worried about inflation and the very...
Published:
Here are a few big biopharma names on which Wall Street is growing more bearish.
Published: